U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. NVDA
3. ONON
4. PSKY
5. META
6. VRTX
7. LGND
8. MA
9. ACN
10. IAUX

Go back to U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
(NYSE: TAK) Delayed: 18.89 --0 (-0%)
Previous Close $18.89    52 Week High $0.55 
Open $18.92    52 Week Low $0.55 
Day High $18.94    P/E N/A 
Day Low $18.81    EPS $-0.20 
Volume 246,849